Table 4.
Baseline characteristics | Patients with total or near-total thyroidectomy (n = 150) | Patients with hemi- or subtotal thyroidectomy (n = 101) | Overall (n = 251) | ||||||
HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | |
Age at operation | |||||||||
≤ 45 yrs | 1.75 | 0.41–7.39 | 0.45 | INF | NC | 0.99 | 2.38 | 0.63–8.98 | 0.20 |
> 45 yrs | 1.00 | - | - | 1.00 | - | - | 1.00 | - | - |
Gender | |||||||||
Men | 5.35 | 1.28–22.4 | 0.02 | 24.2 | 2.17–270 | 0.01 | 7.59 | 2.31–25.0 | 0.001 |
Women | 1.00 | - | - | 1.00 | - | - | 1.00 | - | - |
Tumor size | |||||||||
Per 1 mm increase | 1.17 | 0.79–1.72 | 0.44 | 1.36 | .0.67–2.76 | 0.4 | 1.23 | 0.86–1.74 | 0.26 |
Multifocality | |||||||||
Solitary tumor | 1.58 | 0.38–6.62 | 0.53 | 0.18 | 0.02–1.93 | 0.16 | 0.9 | 0.26–3.08 | 0.86 |
Multifocal tumor | 1.00 | - | - | 1.00 | - | - | 1.00 | - | - |
Extrathyroid extension | |||||||||
Absent | 0.53 | 0.13–2.23 | 0.39 | INF | NC | 1 | 0.77 | 0.23–2.52 | 0.66 |
Present | 1.00 | - | - | 1.00 | - | - | 1.00 | - | - |
Lymph node metastasis | 0.04 | 1 | 0.03 | ||||||
pN0 | 0 | NC | 1 | 0 | NC | 0.99 | 0 | NC | 0.99 |
pN1aa | 1.00 | - | - | 1.00 | - | - | 1.00 | - | - |
pN1bb | 8.25 | 1.66–40.9 | 0.01 | N/A | 5.14 | 1.56–17.0 | 0.007 | ||
Bilaterality | |||||||||
Unilateral tumor | 0.74 | 0.18–3.11 | 0.69 | N/A | 0.65 | 0.17–2.47 | 0.53 | ||
Bilateral tumor | 1.00 | - | - | 1.00 | - | - | |||
Remnant ablation | |||||||||
Not done | 0 | NC | 1 | N/A | N/A | ||||
Done | 1.00 | - | - |
a Metastases to level VI lymph nodes (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes), classified as N1a in the 2002 TNM staging.
b Metastases to unilateral, bilateral, or contralateral cervical superior mediastinal lymph nodes, classified as N1b in the 2002 TNM staging.
Percent recurrence rates were given in parentheses; CI, confidence interval; N/A, not applicable; INF, infinite; NC, cannot calculate; HR, hazard ratio.